Zobrazeno 1 - 10
of 1 043
pro vyhledávání: '"Nimalan A"'
Publikováno v:
Surgery Open Science, Vol 19, Iss , Pp 24-27 (2024)
The treatment of diverticulitis is experiencing a shift in management due to a number of large scale clinical trials. For instance, clinicians are beginning to recognize that avoidance of antibiotics in uncomplicated diverticulitis is not associated
Externí odkaz:
https://doaj.org/article/194fc40478924768adac23466170fce4
Autor:
Qiqi Yang, Sang Woo Park, Chadi M. Saad-Roy, Isa Ahmad, Cécile Viboud, Nimalan Arinaminpathy, Bryan T. Grenfell
Publikováno v:
Epidemics, Vol 48, Iss , Pp 100776- (2024)
Influenza A has two hemagglutinin groups, with stronger cross-immunity to reinfection within than between groups. Here, we explore the implications of this heterogeneity for proposed cross-protective influenza vaccines that may offer broad, but not u
Externí odkaz:
https://doaj.org/article/502ce6e45d444818a41ad05d9f2fdeab
Autor:
C. Finn McQuaid, Nicolas A. Menzies, Rein M.G.J. Houben, Gabriella B. Gomez, Anna Vassall, Nimalan Arinaminpathy, Peter J. Dodd, Richard G. White
Publikováno v:
Epidemics, Vol 48, Iss , Pp 100786- (2024)
We read with great interest the recent paper by Lo et al., who argue that there is an urgent need to ensure the quality of modelling evidence used to support international and national guideline development. Here we outline efforts by the Tuberculosi
Externí odkaz:
https://doaj.org/article/e3b470bf6f914eaa968669151ad02ad0
Publikováno v:
BMJ Open, Vol 14, Iss 3 (2024)
Objectives To estimate the potential impact of expanding services offered by the Joint Effort for Elimination of Tuberculosis (JEET), the largest private sector engagement initiative for tuberculosis (TB) in India.Design We developed a mathematical m
Externí odkaz:
https://doaj.org/article/a97718643b4b49fb8d210ece45ebafdc
Autor:
Juan F. Vesga, Christian Lienhardt, Placide Nsengiyumva, Jonathon R. Campbell, Olivia Oxlade, Saskia den Boon, Dennis Falzon, Kevin Schwartzman, Gavin Churchyard, Nimalan Arinaminpathy
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Recent years have seen important improvements in available preventive treatment regimens for tuberculosis (TB), and research is ongoing to develop these further. To assist with the formulation of target product profiles for future
Externí odkaz:
https://doaj.org/article/9f81b637a7be4a3c97f59c22d3ea0b38
Autor:
David J Haw, Matthew Biggerstaff, Pragati Prasad, Joseph Walker, Bryan Grenfell, Nimalan Arinaminpathy
Publikováno v:
PLoS Computational Biology, Vol 19, Iss 2, p e1010893 (2023)
Influenza pandemics typically occur in multiple waves of infection, often associated with initial emergence of a novel virus, followed (in temperate regions) by a resurgence accompanying the onset of the annual influenza season. Here, we examined whe
Externí odkaz:
https://doaj.org/article/e12511c034ae4dd684cb6999be918b78
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 10, p e0001271 (2023)
Progress towards the 2030 End TB goals has seen severe setbacks due to disruptions arising from the COVID-19 pandemic. For governments and international partner organizations supporting the global TB response, there is a need to assess what level of
Externí odkaz:
https://doaj.org/article/4bb704280b3b46ea94fe9872ddd25676
Publikováno v:
Epidemics, Vol 41, Iss , Pp 100631- (2022)
Background: Diagnostic testing plays a critical role in the global COVID-19 response. Polymerase chain reaction (PCR) tests are highly accurate, but in resource-limited settings, limited capacity has led to testing delays; whereas lateral flow assays
Externí odkaz:
https://doaj.org/article/f5baec72722e47a2a2fae434efd4414e
Autor:
Sourya Shrestha, Emily A. Kendall, Rebekah Chang, Roy Joseph, Parastu Kasaie, Laura Gillini, Anthony Todd Fojo, Michael Campbell, Nimalan Arinaminpathy, David W. Dowdy
Publikováno v:
BMC Medicine, Vol 19, Iss 1, Pp 1-15 (2021)
Abstract Background Global progress towards reducing tuberculosis (TB) incidence and mortality has consistently lagged behind the World Health Organization targets leading to a perception that large reductions in TB burden cannot be achieved. However
Externí odkaz:
https://doaj.org/article/3c5f55fc2f234b92848156b6c0589c26
Autor:
Ntwali Placide Nsengiyumva, Jonathon R Campbell, Olivia Oxlade, Juan F Vesga, Christian Lienhardt, Anete Trajman, Dennis Falzon, Saskia Den Boon, Nimalan Arinaminpathy, Kevin Schwartzman
Publikováno v:
PLoS Medicine, Vol 19, Iss 6, p e1004032 (2022)
BackgroundShorter, safer, and cheaper tuberculosis (TB) preventive treatment (TPT) regimens will enhance uptake and effectiveness. WHO developed target product profiles describing minimum requirements and optimal targets for key attributes of novel T
Externí odkaz:
https://doaj.org/article/d15096b1f12447a894385e967b1b6ff5